Partner With Us NRI

Company details

6M Return -5.52%
1Y Return 8.72%
Mkt Cap.(Cr) 63,676.63
Volume 13,413
Div Yield 0.27%
OI Chg %
Volume 13,413

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

27 May 2022

Entry Price


Target Price



12-18 Month

Rapid Results

Q4FY22 Quarterly Result Announced for Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise declares Q4FY22 result:

  • Q4 FY22 Consolidated Revenues of Rs 35,464 mio (growth of 24% yoy).
  • Q4 FY22 Consolidated EBITDA (Post Ind AS 116) of Rs 4,632 mio.
  • New Hospitals (excl Proton) reported an EBITDA of Rs 826 mio in Q4 FY22 as compared to an EBITDA of Rs 677 mio in Q4 FY21.
  • Proton reported EBITDA (Post Ind AS 116) of Rs 139 mio in Q4 FY22 as compared to EBITDA of Rs 25 mio in Q4 FY21.
  • AHLL reported EBITDA (Post Ind AS 116) of Rs 371 mio in Q4 FY22 as compared to EBITDA Rs 305 mio in Q4FY21.
  • Consolidated PAT of Rs 901 mio in Q4 FY22. PAT before adjusting for tax (business combination U/s Ind AS 103) is Rs 1,783 mio.
  • Ind-AS 116 on operating lease impacted reported PBT in Q4FY22 to the extent of Rs 119 mio.
  • Q4FY22 occupancy across the group was at 4,604 beds (58% occupancy) as compared to 4,631 beds (63% occupancy) in Q4FY21. The Q4FY22 occupancy in mature hospitals was at 3,284 beds (60% occupancy). New hospitals had an occupancy of 1,320 beds (55%) occupancy) in Q4FY22.
  • Inpatient Volumes across the group increased by 7% from 108,169 to 115,902.
  • ARPOB (excluding vaccination) was at Rs 48,510 Vs Rs 43,239 registering a growth of 12% in Q4 FY22 as compared to the same period previous year.



Result PDF


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 5,623.30 Cr FV: 5.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 2,384.58 23,141.09
LAST 3M 49,521.50 -18,551.54
LAST 6M 129,719.68 -157,153.27
LAST 12M 215,295.98 -222,611.80


  • About Company
  • Company Info
  • Listing Info
  • Apollo Hospitals Enterprise Ltd works in the Healthcare sector is having a market capitalization worth Rs. 68,247.55 crores, it was incorporated in the year 1983. It has reported consolidated sales of Rs. 2,867.95 crores in March’2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 508869, and also listed on the National Stock Exchange (NSE) with the code APOLLOHOSP.

    Apollo Hospitals Enterprise Ltd is an Indian international hospital chain having its headquarters in Chennai, Tamil Nadu. Many of the Apollo Hospitals' hospitals have been among the country's first to receive an international healthcare certification from the Joint Commission International (JCI) and the National Accreditation Board for Hospitals and Healthcare Service Providers. Apart from the Hospital business, Apollo has established a presence in Pharmacies, Primary Care, and Diagnostics. Apollo hospitals has a national presence through an established network of over 70 hospitals and 3800 pharmacies spread across the country. The promoters of the company own 29.82% of the stake in the company, Foreign Institutional Investors (FII) own 53.23%, Domestic Institutional Investors (DII) own 11.08% stake in the company, and others (such as public & retail investors) hold the balance of 5.87%.

    In June 2021, quarterly net revenue was Rs. 2,994.71 crores, which has increased sharply by approximately 52.67 % from Rs. 1,961.52 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 150.04 crores, which has improved sharply and increased by nearly 200.62% from a net loss of Rs. 149.11 crores in June 2020. In June 2021, the reported operating profit was at Rs. 2,553.01 crores, which is also increased by 60.55% as compared to an operating profit of Rs. 1,590.2 crores for the quarter ending in June 2020. From a negative EPS of Rs. 10.72 in June 2020, the EPS of Apollo Hospitals Enterprises Ltd has improved and reached Rs. 10.44 per share in June 2021. APOLLOHOSP's stock closed at Rs. 4,746.50 on 20th August’2021 (NSE) and has given a return of 52.78% in the last six months and a return of 179.67% in the previous year.

Read More

Registered Address

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Tel : 91-44-28290956/28293896
Email : apolloshares:vsnl.net
Website : http://www.apollohospitals.com


Integrated Registry Mgt Servic

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 508869
Book Closure Date (Month) : Aug
BSE Group : A
ISIN : INE437A01024

ICICIdirect Apollo Hospitals Enterprise Ltd FAQ

You can buy Apollo Hospitals Enterprise Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Apollo Hospitals Enterprise Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 08, 2022 04:01 PM the closing price of Apollo Hospitals Enterprise Ltd was ₹ 4,428.60.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 08, 2022 04:01 PM, the market cap of Apollo Hospitals Enterprise Ltd stood at ₹ 63,676.63.
The latest PE ratio of Apollo Hospitals Enterprise Ltd as of Aug 08, 2022 04:01 PM is 75.26
The latest PB ratio of Apollo Hospitals Enterprise Ltd as of Aug 08, 2022 04:01 PM is 0.09
The 52-week high of Apollo Hospitals Enterprise Ltd is ₹ 5,930.70 while the 52-week low is ₹ 3,365.90 .
According to analyst recommendations, Apollo Hospitals Enterprise Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote